Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why would the USPTO
The reason the American companies seem to be settling more quickly than the Japanese companies is more than likely a cultural difference in the way the Japanese approach litigation. ARM (a UK company) has not settled for other more strategic reasons IMO having little to do with where there company is based.
Share
New Message
Please login to post a reply